Psoriasis Therapeutics Market Size & Share Report, 2035
The global Psoriasis Therapeutics Market was valued at USD 33.3 billion in 2025 and is anticipated to reach USD 83.3 billion by the end of 2035, expanding at a CAGR of around 9.6% during the forecast period of 2026–2035. The market is experiencing significant growth due to the increasing prevalence of psoriasis and related autoimmune disorders, rising awareness regarding early diagnosis, continuous advancements in biologic therapies, and the growing availability of targeted treatment options.
